Cost-Effectiveness Analysis of Ado-Trastuzumab Emtansine Compared to Lapatinib-Capecitabine Combination In Her2-Positive Metastatic Breast Cancer
May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.1186
https://www.valueinhealthjournal.com/article/S1098-3015(15)01243-7/fulltext
Section Title :
Cancer
Section Order :
647
First Page :
A205
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01243-7&doi=10.1016/j.jval.2015.03.1186